- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02577770
The Effect of Caffeine on Acupuncture Analgesia With the Human Pain Model
A Single Center, Double Blind, Randomized, Parallel-group Study to Assess the Effect of 200mg Caffeine,400mg Caffeine and Decaffeinated on Acupuncture Analgesia With the Human Pain Model
Study Overview
Status
Conditions
Detailed Description
Aim: To evaluate the effect of caffeine on acupuncture analgesia with the human pain model.
Design: Double blind, randomized controlled trial will be performed in Chengdu. The study including two pain models : Potassium pain model and Capsaicin pain model. Both models including the following several groups: 200mg caffeine group, 400mg caffeine group, and decaffeinated group. Participants will be randomly assign to the three groups. Each participants will receive coffee drinking and acupuncture intervention. Each subjects of the Potassium pain model will receive be measured the pain at baseline, 30 minutes after drinking coffee, 10, 20, 30 minutes during acupuncture and 30 minutes after acupuncture intervention completed. Blood samples will be collected at baseline, 30 minutes after drinking coffee, 30 minutes during acupuncture and 30 minutes after acupuncture intervention completed. Each subjects of the capsaicin pain model will be measured the spontaneous pain with VAS scale and the area of hyperalgesia with Von Frey hair at the time of 5 minutes after topical application of capsaicin , 30 minutes after drinking coffee, 10, 20, 30 minutes during acupuncture and 30 minutes after acupuncture intervention completed. Blood samples will be collected at the time of 5 minutes after topical application of capsaicin, 30 minutes after drinking coffee, 30 minutes during acupuncture and 30 minutes after acupuncture intervention completed.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Sichuan
-
Chengdu, Sichuan, China, 610075
- Chengdu University of Traditional Chinese Medicine
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age of a subject is between 18 and 40 years old, male or female
- No known active ongoing disease, in good general health, with a BMI ranging from 18 to 30 kg/m2
- No history of mental disorders,infectious diseases and bleeding disorders. No history of allergic reaction. Females who are not pregnant, lactating, of child-bearing potential, or have no a pregnancy plan within 3 months
- No smoking, drinking alcohol
- No intake of beverage, food and alcohol ,which contains caffeine at least two hours
- No use of any of the methyl purine drugs. No use of any of the drugs ,which can affect the half-life of caffeine, such as: cimetidine, steroids, growth hormone, etc
- No previous experience with acupuncture or other related treatments within 3 days
- Reliable, cooperative, and of adequate intelligence to record the requested information on the questionnaire form
- Informed consent form must be signed by subjects
Exclusion Criteria:
- Subject with serious blood, heart, liver, kidney disease, digestive, or hematopoietic system disease
- Subject with serious mental disorders, infectious diseases and bleeding disorders. Subject has a history of allergic reaction. Females who are pregnant, lactating, of child-bearing potential, or have a pregnancy plan within 3 months;
- Prior use of any type of analgesic drugs before study within 5 half-lives of the drugs
- Use of any of the methyl purine drugs. Use of any of the drugs, which can affect the half-life of caffeine, such as: Sympathomimetic drugs, theophylline drugs , α or β-blockers drugs, and any antihypertensive drugs, etc
- Ingestion of any caffeine-containing beverage, food or alcohol 6 hours or less before study
- Subject has a previous experience with acupuncture or other related treatments within 7 days
- Suffered from medical or psychiatric disorders that prevented them from participating in the study
- Subject who belongs to acupuncture-phobia
Study Plan
How is the study designed?
Design Details
- Primary Purpose: BASIC_SCIENCE
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: QUADRUPLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: 200mg caffeine plus acupuncture
In healthy subjects
|
therapeutic acupuncture treatment with actual needles
8g coffee, po
|
|
Experimental: 400mg caffeine plus acupuncture
In healthy subjects
|
therapeutic acupuncture treatment with actual needles
16g coffee, po
|
|
Placebo Comparator: Decaffeinated plus acupuncture
In healthy subjects
|
therapeutic acupuncture treatment with actual needles
decaffeinated coffee, po
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Change of pain threshold will be measured with Potassium Pain Tester for potassium pain
Time Frame: Baseline, 30 minutes after drinking coffee,10,20,30 minutes during acupuncture and 30 minutes after acupuncture intervention completed
|
Baseline, 30 minutes after drinking coffee,10,20,30 minutes during acupuncture and 30 minutes after acupuncture intervention completed
|
|
Change of pain will be measured with Visual Analog Scale for capsaicin pain
Time Frame: 5 minutes after topical application of capsaicin , 30 minutes after drinking coffee, 10, 20, 30 minutes during acupuncture and 30 minutes after acupuncture intervention completed.
|
5 minutes after topical application of capsaicin , 30 minutes after drinking coffee, 10, 20, 30 minutes during acupuncture and 30 minutes after acupuncture intervention completed.
|
|
Change of pain will be measured with Von Frey Hair for capsaicin pain
Time Frame: 5 minutes after topical application of capsaicin , 30 minutes after drinking coffee, 10, 20, 30 minutes during acupuncture and 30 minutes after acupuncture intervention completed.
|
5 minutes after topical application of capsaicin , 30 minutes after drinking coffee, 10, 20, 30 minutes during acupuncture and 30 minutes after acupuncture intervention completed.
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
The concentration of caffeine in plasma measured by high performance liquid chromatography in both models
Time Frame: one day after the study( blood samples were collected at Baseline, 30 minutes after drinking coffee,30 minutes during acupuncture and 30 minutes after acupuncture intervention completed.
|
one day after the study( blood samples were collected at Baseline, 30 minutes after drinking coffee,30 minutes during acupuncture and 30 minutes after acupuncture intervention completed.
|
|
The concentration of adenosine in plasma measured by high performance liquid
Time Frame: one day after the study( blood samples were collected at Baseline, 30 minutes after drinking coffee,30 minutes during acupuncture and 30 minutes after acupuncture intervention completed.
|
one day after the study( blood samples were collected at Baseline, 30 minutes after drinking coffee,30 minutes during acupuncture and 30 minutes after acupuncture intervention completed.
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2014TD0018
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.